Life Sciences
EUDAMED and the New Reality for Medical Device Companies
What increased transparency means for post-market surveillance and multilingual compliance.
CASE STUDY: Creating a Future-Ready Model for Global MedTech Leader
Discover how a global MedTech leader deployed OPAL Enable to…
From Pressure to Possibility: Key Insights from our MedTech Roundtable
Anja Schaefer, Welocalize Global Head of Commercial for Life Sciences,…
The Silent Bottleneck in Clinical Trials
How translation delays jeopardize First-Patient-In, regulatory submissions, and trial start-up…
CASE STUDY: Multilingual Training Made Simple for Life Sciences Leader
Delivering a 50-minute training video subtitled in 13 languages as…